Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12605165 | 0.88 | ALDH1A1 (0.40) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL5529258 | 0.85 | MEN1 (0.53) | MEN1KMT2AL3MBTL1ALDH1A1EPHX2 | |
| SCHEMBL12017107 | 0.80 | ALDH1A1 (0.47) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL11991799 | 0.80 | ALDH1A1 (0.40) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL5607929 | 0.79 | ALDH1A1 (0.44) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL12378603 | 0.79 | ALDH1A1 (0.42) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL22590271 | 0.78 | ALDH1A1 (0.41) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL5521880 | 0.78 | SCN9A (0.36) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL5608620 | 0.77 | ALDH1A1 (0.45) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 | |
| SCHEMBL17041863 | 0.76 | MAPT (0.41) | SCN9AMEN1KMT2AL3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173353-B2 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-8173353-B2 | Sulfonium compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-05-08 | — | — | US | disclosed |
| US-20100248135-A1 | SULFONIUM COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100248135-A1 | SULFONIUM COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100248135-A1 | SULFONIUM COMPOUND | PFAS, F12, AFF1 | SCN9A 820/4885MEN1 3801/4885KMT2A 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.